Delivery Order SPE2DB24D2205-SPE2DB25FEBDC
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNDUY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,811,175 units of the pharmaceutical product VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed-price pricing type and a ceiling value of $1,142.48. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with ID SPE2DB22D3011|SPE2DB25FQ0ER, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567790829 units of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $1,184.30 and a completion date of April 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,346.26 and a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,720.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567553029 ! VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This contract is a delivery order and has a firm fixed price pricing type. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. The contract does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $1,720.06, is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has a period of performance through June 14, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award, with the ID SPE2DB24D1034|SPE2DB25FWAY4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is valued at $4,917.30 and has an ultimate completion date of March 6, 2025. The contract is for the supply of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, and does not have a set-aside...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FXA58, was made by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of 4,565,891,245 units of the prescription medication VYVANSE 60 MG CAPSULE 100S. This is a firm fixed-price delivery order contract with a ceiling value of $3,115.75 and an ultimate completion date of September 23, 2024. The contract is not set aside for any specific business type....
This federal contract award, with an ID of SPE2DB24D1034|SPE2DB25FVZW6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $1,783.60 and a period of performance through January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,886,214 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The $1,099.48 firm fixed price award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency of the U.S. Department of Defense, on June 12, 2024 with a completion date of June 13, 2024. This order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the...